Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
Can smartphone nudges reduce evening snacking in type 2 diabetes? Explore new CGM research, early results, and implications for personalized care.
Read More »When Evening Snacking Strikes, Can a Smartphone Nudge Change What Happens Next?
Start With the Patient, Not the A1C: What Happens When Visits Ask “What Matters Most?”
What can the QBSafe trial teach us about person-centered diabetes care? Explore its findings on A1C, medication adherence, and patient priorities.
Read More »Diabetes Hospitalizations Aren’t Just About Heart and Kidney Disease Anymore
Explore why diabetes hospitalizations involve more than heart and kidney disease, including infections, respiratory illness, and mental health.
Read More »After DKA or Repeated Low Blood Sugar, Could Attention Problems Linger?
Explore how hypoglycemia and DKA may be linked to attention difficulties in children with type 1 diabetes and what new research reveals.
Read More »Feeding at Night, Dosing by Day: Why Parenteral Nutrition Makes Insulin Management So Difficult
Discover why parenteral nutrition complicates insulin dosing and how CGM-guided adjustments improved glucose control in a small clinical study.
Read More »Could Fenofibrate Slow Diabetic Eye Disease in Type 1 Diabetes?
Can fenofibrate slow diabetic retinopathy in type 1 diabetes? Explore new LENS trial research, potential benefits, safety, and clinical implications.
Read More »Quit Smoking, Protect More Than Your Heart: When Diabetes Complication Risk Starts to Fall
New research links smoking cessation to lower diabetes complication risks. Explore what the findings mean for kidney, eye, and nerve health.
Read More »Three Weeks of Treatment, Months of Better Glucose? A New Diabetes Drug Is Testing an Unusual Idea
Early Phase 1b data suggest balomenib may improve glucose control after treatment ends. Learn what the results could mean for type 2 diabetes.
Read More »The First Years After a Type 2 Diabetes Diagnosis May Matter More Than We Thought
Early hyperglycemia may influence cancer risk after type 2 diabetes diagnosis. See what a large cohort study found about early glycemic exposure.
Read More »Type 2 Diabetes Damages the Pancreas, Or Does It?
New research challenges assumptions about the exocrine pancreas in type 2 diabetes and what pancreatic findings may mean for clinical care.
Read More »